Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1976 Jul;29(7):652–656. doi: 10.1136/jcp.29.7.652

Pneumonia caused by coliforms and Pseudomonas aeruginosa.

P Noone, B T Rogers
PMCID: PMC476135  PMID: 824327

Abstract

The diagnosis and treatment of 20 hospital patients seen in the past year with proven pneumonia caused by coliforms and Pseudomonas aeruginosa are discussed. Predisposing factors and methods for improving laboratory and clinical diagnosis are analysed, the main problem being to discriminate between genuine pneumonia caused by these organisms and mere contamination of sputum samples resulting from colonization of the upper respiratory tract following broad-spectrum chemotherapy. Overall initial chemotherapy with gentamicin cured 75% (15 out of 20) of the patients in spite of unfavourable underlying pathology. Where gentamicin was given in adequate dosage, which in practice meant that dose which produced peak serum concentrations of 8 mug/ml or more, the cure rate was 91% (11 out of 12). In those patients achieving (measured) peak serum concentrations of less than 8 mug/ml the cure rate was only 33% (4 out of 12). These figures include four patients who failed to respond to doses of gentamicin producing peak concentrations of 5-0-6-0 mug/ml in each case. These patients responded promptly to higher doses (or accumulation), producing peak serum concentrations of 8 mug/ml or more and were then cured within three to five days. Toxicity from gentamicin was not observed in any patient. These results indicate that it is necessary to monitor gentamicin therapy by laboratory assay to ensure adequate dosage and that peak serum concentrations of 8 mug/ml or more are significantly correlated with successful treatment of pneumonia caused by coliforms and Ps. aeruginosa.

Full text

PDF
652

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DARRELL J. H., HURDLE A. D. IDENTIFICATION AND CLINICAL SIGNIFICANCE OF KLEBSIELLA SPECIES IN CHEST INFECTIONS. J Clin Pathol. 1964 Nov;17:617–621. doi: 10.1136/jcp.17.6.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. DuPont H. L., Spink W. W. Infections due to gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966. Medicine (Baltimore) 1969 Jul;48(4):307–332. doi: 10.1097/00005792-196907000-00003. [DOI] [PubMed] [Google Scholar]
  3. FINLAND M., JONES W. F., Jr, BARNES M. W. Occurrence of serious bacterial infections since introduction of antibacterial agents. J Am Med Assoc. 1959 Aug 29;170:2188–2197. doi: 10.1001/jama.1959.63010180008012. [DOI] [PubMed] [Google Scholar]
  4. Freeman R. A simple and rapid method for the differentiation of the members of the genus Klebsiella. J Clin Pathol. 1974 Nov;27(11):925–926. doi: 10.1136/jcp.27.11.925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gatmaitan B. G., Carruthers M. M., Lerner A. M. Gentamicin in treatment of primary Gram-negative pneumonias. Am J Med Sci. 1970 Aug;260(2):90–94. doi: 10.1097/00000441-197008000-00003. [DOI] [PubMed] [Google Scholar]
  6. LOWBURY E. J., KIDSON A., LILLY H. A. A NEW SELECTIVE BLOOD AGAR MEDIUM FOR STREPTOCOCCUS PYOGENES AND OTHER HAEMOLYTIC STREPTOCOCCI. J Clin Pathol. 1964 May;17:231–235. doi: 10.1136/jcp.17.3.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Minielly J. A., Mills S. D., Holley K. E. Pneumocystis carinii pneumonia. Can Med Assoc J. 1969 May 10;100(18):846–854. [PMC free article] [PubMed] [Google Scholar]
  8. Mitchell N. J., Harvey A. R. Application of the Stomacher for rapid homogenization of sputum and the serial streak dilution method for quantitative culture. J Clin Pathol. 1975 May;28(5):421–423. doi: 10.1136/jcp.28.5.421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Monroe P. W., Muchmore H. G., Felton F. G., Pirtle J. K. Quantitation of microorganisms in sputum. Appl Microbiol. 1969 Aug;18(2):214–220. doi: 10.1128/am.18.2.214-220.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Noone P., Parsons T. M., Pattison J. R., Slack R. C., Garfield-Davies D., Hughes K. Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis. Br Med J. 1974 Mar 16;1(5906):477–481. doi: 10.1136/bmj.1.5906.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Noone P., Pattison J. R., Davies D. G. The effective use of gentamicin in life-threatening sepsis. Postgrad Med J. 1974 Nov;50 (Suppl 7):9–16. [PubMed] [Google Scholar]
  12. Rawlins G. A. Use of a pancreatin-trypsin solution for the liquefaction of sputa for routine bacteriological examination. J Clin Pathol. 1968 Jul;21(4):531–532. doi: 10.1136/jcp.21.4.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Waterworth P. M. The in-vitro activity of tobramycin compared with that of other aminoglycosides. J Clin Pathol. 1972 Nov;25(11):979–983. doi: 10.1136/jcp.25.11.979. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES